InnovAge vs GeneDx: revenue, profit, margins and growth compared
InnovAge brought in $989.7M of revenue in fiscal 2026, GeneDx $427.5M in fiscal 2025. Revenue changed by +15.9% at InnovAge and +40.0% at GeneDx on the year before, so GeneDx grew faster. InnovAge kept -0.3% of its revenue as net profit, GeneDx -4.9%. Free cash flow was $50.4M at InnovAge and $14.3M at GeneDx.
Fiscal years as each company reports them; the two may end in different months.
Questions about InnovAge and GeneDx
Which is bigger by revenue, InnovAge or GeneDx?
InnovAge is bigger by revenue: $989.7M in fiscal 2026, against $427.5M for GeneDx in fiscal 2025.
Which keeps more of its revenue as profit, InnovAge or GeneDx?
InnovAge had a net margin of -0.3% in fiscal 2026; GeneDx had -4.9% in fiscal 2025.
Which grew revenue faster, InnovAge or GeneDx?
In their latest fiscal years revenue changed by +15.9% at InnovAge and +40.0% at GeneDx.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.